Sanofi's Form 4 filing
Icosavax, Inc. (ICVX) · filed Aug 2, 2021
- Accession no.
- 0000899243-21-031120
- Filed
- Aug 2, 2021
- Trade date
- Aug 2, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market purchases total $1.00M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| SanofiCIK 0001121404 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2021 | Common Stock (par value, $0.0001) | CConversionAcquired | +3,088,502 | $0.00 | $0 | 3,088,502 | Indirect | |
| Aug 2, 2021 | Common Stock (par value, $0.0001) | PPurchaseAcquired | +66,667 | $15.00 | +$1,000,005 | 3,155,169 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2021 | Common Stock | CConversionDisposed | −3,003,224 | – | – | 0 | Indirect | |
| Aug 2, 2021 | Common Stock | CConversionDisposed | −85,278 | – | – | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.